What tumor type is associated with pseudomyxoma peritonei?
Pseudomyxoma peritonei (PMP) is a clinical condition initially thought to be related to ovarian mucinous tumors; however, immunohistochemistry and molecular biology techniques have convincingly made the link to appendiceal mucinous neoplasms, resulting in changes in histologic and clinical approaches.
How is pseudomyxoma peritonei diagnosed?
The diagnosis of pseudomyxoma peritonei may be confirmed by radiologic technologies such as abdominal CT scan or abdominal MRI (magnetic resonance imaging). These imaging tests may reveal the characteristic distribution of large amounts of mucus to particular locations within the abdomen and pelvis.
What are the symptoms of pseudomyxoma peritonei?
What are the symptoms of pseudomyxoma peritonei?
- abdominal or pelvic pain.
- not being able to become pregnant.
- abdominal swelling and bloating.
- changes in bowel habits.
- hernia (a bulge in the tummy wall or groin)
- loss of appetite.
- feeling of fullness.
Why it is called Pseudomyxoma Peritonei?
The term “pseudomyxoma peritonei” was introduced by Werth[2] in 1884, when he described the case of a woman with gelatinous masses in the peritoneal cavity from alleged ruptured pseudomucinous cystadenoma of the ovary, and in which he found to be pseudomucin instead of mucin.
Is PMP curable?
Is there a cure for PMP? Pseudomyxoma peritonei is generally considered treatable but not curable for most patients. As the experience of specialists develops, there are a growing number of PMP patients who are experiencing many years with no evidence of disease (NED) following cytoreductive surgery and HIPEC.
What is the survival rate of PMP?
The median overall survival was 49.3 months. The mean 5-year survival rates of low-grade PMP was 45.2%. The five studies had sufficient data to calculate HRs from the 5-year survival rates data, and three had HRs lower than 1.
How long can you live with Pseudomyxoma Peritonei?
Pseudomyxoma peritonei is an indolent disease, and long-term survival up to 20 years has been described. Cytoreductive surgery is the key to successful treatment in PMP.